Cas No: 2627-69-2
Appearance: white powder
Used:Aicar (AICA-Riboside) strongly inhibits the transcription of PPAR&alpha and the coactivation of
In adipocyte studies it has been shown to antagonize lipolysis induced by isoprenaline
and has been suggested for use in kinase cascade research.
Additionally, research indicates that AICAR blocks the differentiation of 3T3-L1 (sc-2243) adipocytes.
AICAR has been used clinically to treat and protect against cardiac ischemic injury.